This is the age you should treat children for peanut allergies, researchers say
Research out of the University of British Columbia is giving more insight into a treatment designed to help young children overcome peanut allergies.
In 2019, researchers demonstrated that a treatment called oral immunotherapy was successful in treating peanut allergies in preschool-aged children.
They now say the earlier the treatment is given, the better the outcome will be.
"This treatment is affordable, very safe and highly effective, particularly if we can get the treatment going before the infant is 12 months old," says the study's senior author Dr. Edmond Chan in a news release.
The study, published in the Journal of Allergy and Clinical Immunology: In Practice, focused on infants under 12 months old and revealed oral immunotherapy is safer and more effective for this age group than it is for toddlers and older pre-schoolers.
According to Chan, oral immunotherapy is "a treatment protocol in which a patient consumes small amounts of the allergenic food — in this case, peanut flour — with the dose gradually increased to a determined maximum amount."
The goal is to desensitize the child until they're able to consume a full serving of peanut protein without it triggering a dangerous reaction.
The research suggests that children must continue to eat peanut products on a regular basis long-term, in order to sustain their immunity.
Throughout the study, a group of children visited a pediatric allergist every two weeks to receive their peanut dose. Parents were also told to provide the same daily dose at home between clinic visits. After eight to 11 visits, researchers found the children had built up to a "maintenance dose" of 300 milligrams of peanut protein, which is the equivalent of about 1.3 grams of peanuts.
They found that 42 infants completed the build-up period, plus one year of maintenance dosing.
"At the end of it, none of them had more than a mild reaction to a 4,000-milligram dose of peanut protein, compared to 7.7 per cent of the children aged one to five who completed the protocol," the study says.
Seven infants dropped out of the study, with four experiencing reactions beyond mild. Researchers say none of the infants required epinephrine injections as a result.
The study also found during initial testing that only 33.9 per cent of infants had a reaction beyond mild, compared to 53.7 per cent of children aged one through five.
"Despite infants showing the best safety, we were still very satisfied with the safety of this treatment for older pre-schoolers. The risk of a severe reaction is much lower than it is for school-age kids," says Chan.
"Many of the interventions we use in medicine, such as medications or surgical procedures, carry a small amount of risk that is outweighed by the benefit. If this treatment is performed by well-trained allergists and clinicians then I'm really comfortable with the risk. It's actually very safe."
When it comes to long-term effectiveness, researchers say the treatment worked "equally well" for both age groups.
"After a year of one peanut per day, approximately 80 per cent of the children had developed a tolerance for 4,000 milligrams of peanut protein one sitting," the study says.
That's the equivalent of about 15 peanuts.
Chan suggests that parents introduce foods like peanut butter or peanut flour to children around six months of age, to help prevent peanut allergies when they get older.
The head of allergy and immunology in UBC's department of pediatrics at the BC Children's Hospital Research Institute, Chan has embraced oral immunotherapy in his own clinical practice.
His research will be used to inform future clinical practice guidelines, the study says.
CTVNews.ca Top Stories
Montreal doctors' breakthrough discovery about causes of cerebral palsy giving hope
A breakthrough discovery made by doctors at the Montreal Children's Hospital about the causes of cerebral palsy is giving new hope to one West Island family.
Weather alerts issued for 7 provinces, 1 territory
Warnings of up to 60 millimetres of rain and other alerts have been issued for seven Canadian provinces and one territory ahead of the Easter weekend.
Ontario homeowner on the hook for $27,000 when contractor severed power line
An Ontario man who built a garage on his property has been locked in a battle with his electricity provider for a year and half over a severed power line.
For years she thought her son had died of an overdose. The police video changed all that
Austin Hunter Turner died in 2017, on a night that his mother has rewound and replayed again and again, trying to make sense of what happened.
Grandparent scam: London, Ont., senior beats fraudsters not once, but twice
It was a typical Tuesday for Mabel Beharrell, 84, until she got the call that would turn her world upside down. Her teenaged grandson was in trouble and needed her help.
CRA no longer requiring 'bare trust' reporting in 2023 tax return
The Canada Revenue Agency announced Thursday it will not require 'bare trust' reporting from Canadians that it introduced for the 2024 tax season, just four days before the April 2 deadline.
Why Kim Kardashian is being sued for 'knockoff' furniture
The estate of minimalist contemporary artist Donald Judd filed a lawsuit against Kardashian this week, claiming the fashion and beauty mogul promoted 'cheap knockoffs' of his furniture designs.
Where is the worst place for allergy sufferers in Canada?
The spring allergy season has started early in many parts of Canada, with high levels of pollen in some cities already. Experts weigh in on which areas have it worse so far this season.
Louis Gossett Jr., 1st Black man to win supporting actor Oscar, dies at 87
Louis Gossett Jr., the first Black man to win a supporting actor Oscar and an Emmy winner for his role in the seminal TV miniseries 'Roots,' has died. He was 87.